APO RESEARCH · REPORT
Anti-inflammatory Therapeutics
Anti-inflammatory therapeutics are treatments for arthritis, respiratory diseases, dermatology, psoriasis, inflammatory bowel disease and other inflammatory diseases. The treatments include anti-inflammatory biologics, NSAIDs, corticosteroids and others.
Product & engineering
Understand the product.
Anti-inflammatory therapeutics are treatments for arthritis, respiratory diseases, dermatology, psoriasis, inflammatory bowel disease and other inflammatory diseases. The treatments include anti-inflammatory biologics, NSAIDs, corticosteroids and others.
Selected research
Industry Research
Anti-inflammatory Therapeutics Industry Research Report 2026
Market perspective
Anti-inflammatory therapeutics are treatments for arthritis, respiratory diseases, dermatology, psoriasis, inflammatory bowel disease and other inflammatory diseases. The treatments include anti-inflammatory biologics, NSAIDs, corticosteroids and others.
Top 5 manufacturers make up the major market share in the anti-inflammatory therapeutics market. AbbVie maintained its first place in the ranking in 2019, accounted for 21.59% market share. Other players accounted for 14.20%, 5.43%, 5.32% including Johnson & Johnson, Amgen Inc, AstraZeneca PLC.
Report Scope
Read the full market overview
This report quantifies the global Anti-inflammatory Therapeutics market in terms of revenue (US$ million) and, where applicable, service volume (), using 2024 as the base year and providing annual historical and forecast data for 2021–2032.
It standardizes definitions of service Types and end-use Applications, harmonizes provider attribution, and delivers comparable time series by company, Type, Application, and region or country, including indicative price bands (US$/) and concentration ratios (CR5/CR10). Outputs are intended to support service design, budgeting, capacity planning, and benchmarking for providers, platforms, channel partners, and investors; the report also reviews technology shifts and notable service innovations relevant to Anti-inflammatory Therapeutics.
Key Companies & Market Share Insights
This section profiles leading service providers with 2021–2025 results and a 2026–2032 outlook—covering revenue, market share, price bands, service portfolio and client mix, regional and channel mix, and key developments (M&A, network expansion, certifications). It also provides global revenue, average price, and—where applicable—volume metrics by provider, and calculates CR5/CR10 and rank changes to support comparative benchmarking.
Anti-inflammatory Therapeutics Market by Company
AbbVie
Johnson & Johnson
Amgen Inc
AstraZeneca PLC
Pfizer, Inc
Novartis
Roche
Merck
Sanofi
GlaxoSmithKline
Sun Pharmaceutical Industries Ltd
TEVA
Anti-inflammatory Therapeutics Segment by Type
Anti-inflammatory Biologics
Non-Steroidal Anti-inflammatory Drugs (NSAIDs)
Corticosteroids
Others
Anti-inflammatory Therapeutics Segment by Application
Arthritis
Respiratory Diseases
Dermatology
Gastroenterology
Others
Anti-inflammatory Therapeutics Segment by Region
North America
United States
Canada
Mexico
Europe
Germany
France
U.K.
Italy
Spain
Russia
Netherlands
Nordic Countries
Asia-Pacific
China
Japan
South Korea
India
Australia
Taiwan
Southeast Asia
South America
Brazil
Argentina
Chile
Middle East & Africa
Saudi Arabia
Israel
United Arab Emirates
Turkey
Iran
Egypt
Key Drivers & Barriers
High-impact rendering factors and drivers have been studied in this report to aid the readers to understand the general development. Moreover, the report includes restraints and challenges that may act as stumbling blocks on the way of the players. This will assist the users to be attentive and make informed decisions related to business. Specialists have also laid their focus on the upcoming business prospects.
Reasons to Buy This Report
1. This report will help the readers to understand the competition within the industries and strategies for the competitive environment to enhance the potential profit. The report also focuses on the competitive landscape of the global Anti-inflammatory Therapeutics market, and introduces in detail the market share, industry ranking, competitor ecosystem, market performance, new product development, operation situation, expansion, and acquisition. etc. of the main players, which helps the readers to identify the main competitors and deeply understand the competition pattern of the market.
2. This report will help stakeholders to understand the global industry status and trends of Anti-inflammatory Therapeutics and provides them with information on key market drivers, restraints, challenges, and opportunities.
3. This report will help stakeholders to understand competitors better and gain more insights to strengthen their position in their businesses. The competitive landscape section includes the market share and rank (in volume and value), competitor ecosystem, new product development, expansion, and acquisition.
4. This report stays updated with novel technology integration, features, and the latest developments in the market
5. This report helps stakeholders to gain insights into which regions to target globally
6. This report helps stakeholders to gain insights into the end-user perception concerning the adoption of Anti-inflammatory Therapeutics.
7. This report helps stakeholders to identify some of the key players in the market and understand their valuable contribution.
Chapter Outline
Chapter 1: Research objectives, research methods, data sources, data cross-validation;
Chapter 2: Introduces the report scope of the report, executive summary of different market segments (product type, application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
Chapter 3: Provides the analysis of various market segments product types, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 4: Provides the analysis of various market segments application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 5: Introduces executive summary of global market size, regional market size, this section also introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by companies in the industry, and the analysis of relevant policies in the industry.
Chapter 6: Detailed analysis of Anti-inflammatory Therapeutics companies’ competitive landscape, revenue market share, latest development plan, merger, and acquisition information, etc.
Chapter 7, 8, 9, 10, 11: North America, Europe, Asia Pacific, South America, Middle East and Africa segment by country. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and capacity of each country in the world.
Chapter 12: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including revenue, gross margin, product introduction, recent development, etc.
Chapter 13: The main points and conclusions of the report.
More report detail
Tables and figures
Scope & coverage.
Types
- Anti-inflammatory Biologics
- Non-Steroidal Anti-inflammatory Drugs (NSAIDs)
- Corticosteroids
- Others
Applications
- Arthritis
- Respiratory Diseases
- Dermatology
- Gastroenterology
- Others
Companies covered
- AbbVie
- Johnson & Johnson
- Amgen Inc
- AstraZeneca PLC
- Pfizer, Inc
- Novartis
- Roche
- Merck
- Sanofi
- GlaxoSmithKline
- Sun Pharmaceutical Industries Ltd
- TEVA
Inside the report.
1 Preface
- 1.1 Scope of Report
- 1.2 Reasons for Doing This Study
- 1.3 Research Methodology
- 1.4 Research Process
- 1.5 Data Source
- 1.5.1 Secondary Sources
- 1.5.2 Primary Sources
2 Market Overview
- 2.1 Product Definition
- 2.2 Anti-inflammatory Therapeutics by Type
- 2.2.1 Market Value Comparison by Type (2021 VS 2025 VS 2032)
- 2.2.2 Anti-inflammatory Biologics
- 2.2.3 Non-Steroidal Anti-inflammatory Drugs (NSAIDs)
- 2.2.4 Corticosteroids
- 2.2.5 Others
- 2.3 Anti-inflammatory Therapeutics by Application
- 2.3.1 Market Value Comparison by Application (2021 VS 2025 VS 2032)
- 2.3.2 Arthritis
- 2.3.3 Respiratory Diseases
- 2.3.4 Dermatology
- 2.3.5 Gastroenterology
- 2.3.6 Others
- 2.4 Assumptions and Limitations
3 Anti-inflammatory Therapeutics Breakdown Data by Type
- 3.1 Global Anti-inflammatory Therapeutics Historic Market Size by Type (2021-2026)
- 3.2 Global Anti-inflammatory Therapeutics Forecasted Market Size by Type (2027-2032)
4 Anti-inflammatory Therapeutics Breakdown Data by Application
- 4.1 Global Anti-inflammatory Therapeutics Historic Market Size by Application (2021-2026)
- 4.2 Global Anti-inflammatory Therapeutics Forecasted Market Size by Application (2027-2032)
5 Global Growth Trends
- 5.1 Global Anti-inflammatory Therapeutics Market Perspective (2021-2032)
- 5.2 Global Anti-inflammatory Therapeutics Growth Trends by Region
- 5.2.1 Global Anti-inflammatory Therapeutics Market Size by Region: 2021 VS 2025 VS 2032
- 5.2.2 Anti-inflammatory Therapeutics Historic Market Size by Region (2021-2026)
- 5.2.3 Anti-inflammatory Therapeutics Forecasted Market Size by Region (2027-2032)
- 5.3 Anti-inflammatory Therapeutics Market Dynamics
- 5.3.1 Anti-inflammatory Therapeutics Industry Trends
- 5.3.2 Anti-inflammatory Therapeutics Market Drivers
- 5.3.3 Anti-inflammatory Therapeutics Market Challenges
- 5.3.4 Anti-inflammatory Therapeutics Market Restraints
6 Market Competitive Landscape by Players
- 6.1 Global Top Anti-inflammatory Therapeutics Players by Revenue
- 6.1.1 Global Top Anti-inflammatory Therapeutics Players by Revenue (2021-2026)
- 6.1.2 Global Anti-inflammatory Therapeutics Revenue Market Share by Players (2021-2026)
- 6.2 Global Anti-inflammatory Therapeutics Industry Players Ranking, 2023 VS 2024 VS 2025
- 6.3 Global Key Players of Anti-inflammatory Therapeutics Head Office and Area Served
- 6.4 Global Anti-inflammatory Therapeutics Players, Product Type & Application
- 6.5 Global Anti-inflammatory Therapeutics Manufacturers Established Date
- 6.6 Global Anti-inflammatory Therapeutics Market CR5 and HHI
- 6.7 Global Players Mergers & Acquisition
7 North America
- 7.1 North America Anti-inflammatory Therapeutics Market Size (2021-2032)
- 7.2 North America Anti-inflammatory Therapeutics Market Growth Rate by Country: 2021 VS 2025 VS 2032
- 7.3 North America Anti-inflammatory Therapeutics Market Size by Country (2021-2026)
- 7.4 North America Anti-inflammatory Therapeutics Market Size by Country (2027-2032)
- 7.5 United States
- 7.5 United States
- 7.6 Canada
- 7.7 Mexico
8 Europe
- 8.1 Europe Anti-inflammatory Therapeutics Market Size (2021-2032)
- 8.2 Europe Anti-inflammatory Therapeutics Market Growth Rate by Country: 2021 VS 2025 VS 2032
- 8.3 Europe Anti-inflammatory Therapeutics Market Size by Country (2021-2026)
- 8.4 Europe Anti-inflammatory Therapeutics Market Size by Country (2027-2032)
- 8.5 Germany
- 8.6 France
- 8.7 U.K.
- 8.8 Italy
- 8.9 Spain
- 8.10 Russia
- 8.11 Netherlands
- 8.12 Nordic Countries
9 Asia-Pacific
- 9.1 Asia-Pacific Anti-inflammatory Therapeutics Market Size (2021-2032)
- 9.2 Asia-Pacific Anti-inflammatory Therapeutics Market Growth Rate by Country: 2021 VS 2025 VS 2032
- 9.3 Asia-Pacific Anti-inflammatory Therapeutics Market Size by Country (2021-2026)
- 9.4 Asia-Pacific Anti-inflammatory Therapeutics Market Size by Country (2027-2032)
- 9.5 China
- 9.6 Japan
- 9.7 South Korea
- 9.8 India
- 9.9 Australia
- 9.10 China Taiwan
- 9.11 Southeast Asia
10 South America
- 10.1 South America Anti-inflammatory Therapeutics Market Size (2021-2032)
- 10.2 South America Anti-inflammatory Therapeutics Market Growth Rate by Country: 2021 VS 2025 VS 2032
- 10.3 South America Anti-inflammatory Therapeutics Market Size by Country (2021-2026)
- 10.4 South America Anti-inflammatory Therapeutics Market Size by Country (2027-2032)
- 10.5 Brazil
- 10.6 Argentina
- 10.7 Chile
- 10.8 Colombia
- 10.9 Peru
11 Middle East & Africa
- 11.1 Middle East & Africa Anti-inflammatory Therapeutics Market Size (2021-2032)
- 11.2 Middle East & Africa Anti-inflammatory Therapeutics Market Growth Rate by Country: 2021 VS 2025 VS 2032
- 11.3 Middle East & Africa Anti-inflammatory Therapeutics Market Size by Country (2021-2026)
- 11.4 Middle East & Africa Anti-inflammatory Therapeutics Market Size by Country (2027-2032)
- 11.5 Saudi Arabia
- 11.6 Israel
- 11.7 United Arab Emirates
- 11.8 Turkey
- 11.9 Iran
- 11.10 Egypt
12 Players Profiled
- 12.1 AbbVie
- 12.1.1 AbbVie Company Information
- 12.1.2 AbbVie Business Overview
- 12.1.3 AbbVie Revenue in Anti-inflammatory Therapeutics Business (2021-2026)
- 12.1.4 AbbVie Anti-inflammatory Therapeutics Product Portfolio
- 12.1.5 AbbVie Recent Developments
- 12.2 Johnson & Johnson
- 12.2.1 Johnson & Johnson Company Information
- 12.2.2 Johnson & Johnson Business Overview
- 12.2.3 Johnson & Johnson Revenue in Anti-inflammatory Therapeutics Business (2021-2026)
- 12.2.4 Johnson & Johnson Anti-inflammatory Therapeutics Product Portfolio
- 12.2.5 Johnson & Johnson Recent Developments
- 12.3 Amgen Inc
- 12.3.1 Amgen Inc Company Information
- 12.3.2 Amgen Inc Business Overview
- 12.3.3 Amgen Inc Revenue in Anti-inflammatory Therapeutics Business (2021-2026)
- 12.3.4 Amgen Inc Anti-inflammatory Therapeutics Product Portfolio
- 12.3.5 Amgen Inc Recent Developments
- 12.4 AstraZeneca PLC
- 12.4.1 AstraZeneca PLC Company Information
- 12.4.2 AstraZeneca PLC Business Overview
- 12.4.3 AstraZeneca PLC Revenue in Anti-inflammatory Therapeutics Business (2021-2026)
- 12.4.4 AstraZeneca PLC Anti-inflammatory Therapeutics Product Portfolio
- 12.4.5 AstraZeneca PLC Recent Developments
- 12.5 Pfizer, Inc
- 12.5.1 Pfizer, Inc Company Information
- 12.5.2 Pfizer, Inc Business Overview
- 12.5.3 Pfizer, Inc Revenue in Anti-inflammatory Therapeutics Business (2021-2026)
- 12.5.4 Pfizer, Inc Anti-inflammatory Therapeutics Product Portfolio
- 12.5.5 Pfizer, Inc Recent Developments
- 12.6 Novartis
- 12.6.1 Novartis Company Information
- 12.6.2 Novartis Business Overview
- 12.6.3 Novartis Revenue in Anti-inflammatory Therapeutics Business (2021-2026)
- 12.6.4 Novartis Anti-inflammatory Therapeutics Product Portfolio
- 12.6.5 Novartis Recent Developments
- 12.7 Roche
- 12.7.1 Roche Company Information
- 12.7.2 Roche Business Overview
- 12.7.3 Roche Revenue in Anti-inflammatory Therapeutics Business (2021-2026)
- 12.7.4 Roche Anti-inflammatory Therapeutics Product Portfolio
- 12.7.5 Roche Recent Developments
- 12.8 Merck
- 12.8.1 Merck Company Information
- 12.8.2 Merck Business Overview
- 12.8.3 Merck Revenue in Anti-inflammatory Therapeutics Business (2021-2026)
- 12.8.4 Merck Anti-inflammatory Therapeutics Product Portfolio
- 12.8.5 Merck Recent Developments
- 12.9 Sanofi
- 12.9.1 Sanofi Company Information
- 12.9.2 Sanofi Business Overview
- 12.9.3 Sanofi Revenue in Anti-inflammatory Therapeutics Business (2021-2026)
- 12.9.4 Sanofi Anti-inflammatory Therapeutics Product Portfolio
- 12.9.5 Sanofi Recent Developments
- 12.10 GlaxoSmithKline
- 12.10.1 GlaxoSmithKline Company Information
- 12.10.2 GlaxoSmithKline Business Overview
- 12.10.3 GlaxoSmithKline Revenue in Anti-inflammatory Therapeutics Business (2021-2026)
- 12.10.4 GlaxoSmithKline Anti-inflammatory Therapeutics Product Portfolio
- 12.10.5 GlaxoSmithKline Recent Developments
- 12.11 Sun Pharmaceutical Industries Ltd
- 12.11.1 Sun Pharmaceutical Industries Ltd Company Information
- 12.11.2 Sun Pharmaceutical Industries Ltd Business Overview
- 12.11.3 Sun Pharmaceutical Industries Ltd Revenue in Anti-inflammatory Therapeutics Business (2021-2026)
- 12.11.4 Sun Pharmaceutical Industries Ltd Anti-inflammatory Therapeutics Product Portfolio
- 12.11.5 Sun Pharmaceutical Industries Ltd Recent Developments
- 12.12 TEVA
- 12.12.1 TEVA Company Information
- 12.12.2 TEVA Business Overview
- 12.12.3 TEVA Revenue in Anti-inflammatory Therapeutics Business (2021-2026)
- 12.12.4 TEVA Anti-inflammatory Therapeutics Product Portfolio
- 12.12.5 TEVA Recent Developments
13 Report Conclusion
14 Disclaimer
GET THE RESEARCH
Choose your license.
Choose who needs access.
All options are for this report and research series.
PDF by email within 3–5 working days after payment confirmation.
Talk to an analyst